Project Grant HT94252410994
Award Date
11/15/24
Completion Date
11/14/27
Dollars Obligated
$524K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Great Britain, United Kingdom
Similar Awards
The University of Manchester was awarded a $616,695 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on brain charts in children and adolescents with neurofibromatosis type 1. The 3-year grant, awarded on July 15, 2024, will support the university's efforts to advance understanding of the neurological impacts of this genetic disorder. The research aims to develop improved diagnostic tools and inform...
The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
The Department of the Army Medical Command awarded a $161,500 Project Grant to The Regents of the University of California, San Francisco to support research investigating the mechanisms and consequences of Hedgehog signaling and immune infiltration in schwannoma. The award period is from July 15, 2021 through July 14, 2023. The research is being conducted under the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health through...
The University of Manchester received a $396,778 Project Grant award from the Defense Health Agency to model the risk of radiation-associated malignant progression in familial Neurofibromatosis type 2 (NF2) using machine learning approaches. The award was made under the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to improve military and public health care through innovative solutions for battlefield medicine and other areas. Over a...
This federal Project Grant award of $968,875.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida. The grant will fund a 3-year project focused on the identification and assessment of targets for immunotherapy in NF2-associated schwannomatosis, a rare genetic disorder. The research aims to advance the understanding and treatment of...
This $847,875 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports research at the University of Virginia aimed at understanding the role of the Schwann cell tumor microenvironment in the development of neurofibromas. The project will take place over 3 years from September 2025 to August 2028. The research seeks to advance scientific understanding of this medical condition relevant to...
The University of Minnesota was awarded a $479,946 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...
The U.S. Department of Defense (DoD) awarded a $334,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), on September 15, 2023. The award supports a 2-year research project titled "TARGETING THE NF-KB PATHWAY TO TREAT NF1-DEFICIENT TUMORS." Through this funding, MGH will conduct biomedical research to investigate novel approaches for treating tumors caused...
The University of Minnesota will leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors under a $548,892 project grant from the Defense Health Agency. The grant was awarded on August 1, 2023 with a completion date of July 31, 2026. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care through...
This $485,597.91 federal Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to support research at the Universite De Sherbrooke in Canada. The award will fund a 3-year project from August 1, 2024 to July 31, 2027 focused on understanding the "CONTRIBUTION OF ALTERNATIVE SPLICING TO NEUROFIBROMAGENESIS." The research aims to advance scientific knowledge in the area of neurological disorders, which...